The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors

Heidi Rye Hudlebusch, Eric Santoni-Rugiu, Ronald Simon, Elisabeth Ralfkiær, Henrik Holm Rossing, Jens Vilstrup Johansen, Mette Jørgensen, Guido Sauter, Kristian Helin

    Research output: Contribution to journalJournal articleResearchpeer-review

    114 Citations (Scopus)

    Abstract

    Multiple myeloma SET (Suppressor of variegation, Enhancer of zeste, and Trithorax) domain (MMSET) is a histone lysine methyltransferase deregulated in a subgroup of multiple myelomas with the t(4;14)(p16;q32) translocation and poor prognosis. With the aim of understanding, if MMSET can be involved in other types of cancer we investigated the expression of MMSET protein in different types of human tumors.
    Original languageEnglish
    JournalClinical Cancer Research
    Volume17
    Issue number9
    Pages (from-to)2919-33
    Number of pages15
    ISSN1078-0432
    DOIs
    Publication statusPublished - 2011

    Keywords

    • Animals
    • Antibodies, Monoclonal
    • Antibody Specificity
    • Female
    • Gene Expression Regulation, Enzymologic
    • Gene Expression Regulation, Neoplastic
    • Histone-Lysine N-Methyltransferase
    • Humans
    • Male
    • Mice
    • Models, Biological
    • Neoplasms
    • Oncogene Proteins
    • Repressor Proteins
    • Tissue Array Analysis
    • Tumor Cells, Cultured
    • Up-Regulation

    Cite this